Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-May-24 5:00 PM View:  | Abbott Laboratories (ABT) | 07-May-24 | Sale | 22,852 | $106.25 | $2,428,120.00 | (27%) 84.31K to 61.46K | |
| 04-Mar-24 6:50 PM View: | Abbott Laboratories (ABT) | 01-Mar-24 | Sale | 694 | $118.50 | $82,239.00 | (< 1%) 85.01K to 84.31K | |
| 04-Mar-24 6:50 PM View: | Abbott Laboratories (ABT) | 29-Feb-24 | Payment of Exercise | 7,669 | $120.05 | $920,664.00 | (8%) 92.68K to 85.01K | |
| 23-Feb-24 5:33 PM View: | Abbott Laboratories (ABT) | 21-Feb-24 | Grant | 17,240 | -- | -- | 23% 75.44K to 92.68K | |
| 02-Mar-23 7:27 PM View: | Abbott Laboratories (ABT) | 01-Mar-23 | Sale | 943 | $100.70 | $94,960.10 | (1%) 76.38K to 75.44K | |
| 02-Mar-23 7:27 PM View: | Abbott Laboratories (ABT) | 28-Feb-23 | Payment of Exercise | 7,631 | $99.77 | $761,345.00 | (9%) 84.01K to 76.38K | |
| 22-Feb-23 6:48 PM View: | Abbott Laboratories (ABT) | 17-Feb-23 | Grant | 15,855 | -- | -- | 23% 68.16K to 84.01K | |
| 14-Jun-22 5:18 PM View: | Abbott Laboratories (ABT) | 10-Jun-22 | Payment of Exercise | 22,474 | $112.71 | $2,533,040.00 | (25%) 90.63K to 68.16K | |
| 02-Mar-22 7:38 PM View: | Abbott Laboratories (ABT) | 01-Mar-22 | Sale | 943 | $118.15 | $111,416.00 | (1%) 91.57K to 90.63K | |
| 02-Mar-22 7:38 PM View: | Abbott Laboratories (ABT) | 28-Feb-22 | Payment of Exercise | 5,168 | $122.41 | $632,615.00 | (5%) 96.74K to 91.57K | (10%) |
| 23-Feb-22 8:07 PM View: | Abbott Laboratories (ABT) | 18-Feb-22 | Grant | 17,247 | -- | -- | 22% 79.49K to 96.74K | |
| 11-Jun-21 5:09 PM View: | Abbott Laboratories (ABT) | 10-Jun-21 | Payment of Exercise | 2,881 | $109.05 | $314,173.00 | (3%) 82.38K to 79.49K | (1%) |
| 02-Mar-21 7:16 PM View: | Abbott Laboratories (ABT) | 01-Mar-21 | Market Sale | 943 | $120.61 | $113,735.00 | (1%) 83.32K to 82.38K | (1%) |
| 02-Mar-21 7:16 PM View: | Abbott Laboratories (ABT) | 26-Feb-21 | Payment of Exercise | 2,621 | $121.58 | $318,661.00 | (3%) 85.94K to 83.32K | (< 1%) |
| 23-Feb-21 6:45 PM View: | Abbott Laboratories (ABT) | 19-Feb-21 | Grant | 13,865 | -- | -- | 19% 72.07K to 85.94K | |
| 12-Jun-20 5:07 PM View: | Abbott Laboratories (ABT) | 10-Jun-20 | Payment of Exercise | 2,855 | $90.27 | $257,721.00 | (4%) 75.8K to 72.95K | (19%) |
| 12-Jun-20 5:07 PM View: | Abbott Laboratories (ABT) | 10-Jun-20 | Market Sale | 872 | $90.84 | $79,216.00 | (1%) 72.95K to 72.07K | (18%) |
| 25-Feb-20 5:36 PM View: | Abbott Laboratories (ABT) | 21-Feb-20 | Grant | 18,855 | -- | -- | 33% 56.95K to 75.8K | |
| 12-Jun-19 5:08 PM View: | Abbott Laboratories (ABT) | 10-Jun-19 | Grant | 56,946 | -- | -- | 100% 0 to 56.95K | |
| 17-May-19 4:06 PM View: | Intersect Ent, Inc. (XENT) | 15-May-19 | Option Exercise | 9,500 | $13.05 | $123,975.00 | 2% 448.17K to 457.67K | |
| 17-May-19 4:06 PM View: | Intersect Ent, Inc. (XENT) | 15-May-19 | Market Option Sale (Planned) | 9,500 | $25.59 | $243,102.00 | (2%) 457.67K to 448.17K | 12% |
| 17-Apr-19 3:48 PM View: | Intersect Ent, Inc. (XENT) | 15-Apr-19 | Option Exercise | 13,516 | $7.78 | $105,094.00 | 3% 464.24K to 477.75K | |
| 17-Apr-19 3:48 PM View: | Intersect Ent, Inc. (XENT) | 15-Apr-19 | Market Option Sale (Planned) | 13,516 | $28.43 | $384,286.00 | (3%) 477.75K to 464.24K | 21% |
| 17-Apr-19 3:48 PM View: | Intersect Ent, Inc. (XENT) | 15-Apr-19 | Market Sale (Planned) | 16,072 | $28.43 | $456,958.00 | (3%) 464.24K to 448.17K | 21% |
| 18-Jan-19 5:38 PM View: | Intersect Ent, Inc. (XENT) | 16-Jan-19 | Grant | 33,800 | -- | -- | 8% 430.44K to 464.24K | |
| 03-Jan-19 8:11 PM View: | Intersect Ent, Inc. (XENT) | 01-Jan-19 | Payment of Exercise | 10,428 | $26.57 | $277,046.00 | (2%) 440.87K to 430.44K | 15% |
| 26-Dec-18 12:43 PM View: | Intersect Ent, Inc. (XENT) | 20-Dec-18 | Option Exercise | 35,000 | $1.20 | $42,000.00 | 9% 405.87K to 440.87K | |
| 19-Dec-18 5:16 PM View: | Intersect Ent, Inc. (XENT) | 17-Dec-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | 1% 420.87K to 425.87K | |
| 19-Dec-18 5:16 PM View: | Intersect Ent, Inc. (XENT) | 17-Dec-18 | Market Option Sale (Planned) | 5,000 | $29.73 | $148,626.00 | (1%) 425.87K to 420.87K | 24% |
| 19-Dec-18 5:16 PM View: | Intersect Ent, Inc. (XENT) | 17-Dec-18 | Market Sale (Planned) | 15,000 | $29.73 | $445,878.00 | (4%) 420.87K to 405.87K | 24% |
| 19-Nov-18 10:00 PM View: | Intersect Ent, Inc. (XENT) | 15-Nov-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | 1% 435.87K to 440.87K | |
| 19-Nov-18 10:00 PM View: | Intersect Ent, Inc. (XENT) | 15-Nov-18 | Market Option Sale (Planned) | 5,000 | $30.01 | $150,074.00 | (1%) 440.87K to 435.87K | 25% |
| 19-Nov-18 10:00 PM View: | Intersect Ent, Inc. (XENT) | 15-Nov-18 | Market Sale (Planned) | 15,000 | $30.01 | $450,222.00 | (3%) 435.87K to 420.87K | 25% |
| 17-Oct-18 6:54 PM View: | Intersect Ent, Inc. (XENT) | 15-Oct-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | 1% 450.87K to 455.87K | |
| 17-Oct-18 6:54 PM View: | Intersect Ent, Inc. (XENT) | 15-Oct-18 | Market Option Sale (Planned) | 5,000 | $29.63 | $148,154.00 | (1%) 455.87K to 450.87K | 24% |
| 17-Oct-18 6:54 PM View: | Intersect Ent, Inc. (XENT) | 15-Oct-18 | Market Sale (Planned) | 15,000 | $29.63 | $444,460.00 | (3%) 450.87K to 435.87K | 24% |
| 19-Sep-18 5:27 PM View: | Intersect Ent, Inc. (XENT) | 17-Sep-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | 1% 465.87K to 470.87K | |
| 19-Sep-18 5:27 PM View: | Intersect Ent, Inc. (XENT) | 17-Sep-18 | Market Option Sale (Planned) | 5,000 | $29.14 | $145,716.00 | (1%) 470.87K to 465.87K | 23% |
| 19-Sep-18 5:27 PM View: | Intersect Ent, Inc. (XENT) | 17-Sep-18 | Market Sale (Planned) | 15,000 | $29.14 | $437,146.00 | (3%) 465.87K to 450.87K | 23% |
| 17-Aug-18 7:05 PM View: | Intersect Ent, Inc. (XENT) | 15-Aug-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | 1% 480.87K to 485.87K | |
| 17-Aug-18 7:05 PM View: | Intersect Ent, Inc. (XENT) | 15-Aug-18 | Market Option Sale (Planned) | 5,000 | $26.51 | $132,548.00 | (1%) 485.87K to 480.87K | 15% |
| 17-Aug-18 7:05 PM View: | Intersect Ent, Inc. (XENT) | 15-Aug-18 | Market Sale (Planned) | 15,000 | $26.51 | $397,646.00 | (3%) 480.87K to 465.87K | 15% |
| 18-Jul-18 6:09 PM View: | Intersect Ent, Inc. (XENT) | 16-Jul-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | 1% 495.87K to 500.87K | |
| 18-Jul-18 6:09 PM View: | Intersect Ent, Inc. (XENT) | 16-Jul-18 | Market Option Sale (Planned) | 5,000 | $33.08 | $165,422.00 | (< 1%) 500.87K to 495.87K | 32% |
| 18-Jul-18 6:09 PM View: | Intersect Ent, Inc. (XENT) | 16-Jul-18 | Market Sale (Planned) | 15,000 | $33.08 | $496,264.00 | (3%) 495.87K to 480.87K | 32% |
| 19-Jun-18 5:22 PM View: | Intersect Ent, Inc. (XENT) | 15-Jun-18 | Option Exercise | 5,000 | $13.05 | $65,250.00 | < 1% 510.87K to 515.87K | |
| 19-Jun-18 5:22 PM View: | Intersect Ent, Inc. (XENT) | 15-Jun-18 | Market Option Sale (Planned) | 5,000 | $36.79 | $183,928.00 | (< 1%) 515.87K to 510.87K | 39% |
| 19-Jun-18 5:22 PM View: | Intersect Ent, Inc. (XENT) | 15-Jun-18 | Market Sale (Planned) | 15,000 | $36.79 | $551,782.00 | (3%) 510.87K to 495.87K | 39% |
| 23-May-18 7:16 PM View: | Nevro Corp (NVRO) | 21-May-18 | Grant | 3,785 | -- | -- | 249% 1.52K to 5.3K | |
| 17-May-18 4:39 PM View: | Intersect Ent, Inc. (XENT) | 15-May-18 | Option Exercise | 15,000 | $13.05 | $195,750.00 | 3% 510.87K to 525.87K |